Pivotal bioVenture Partners

San Francisco, California
cb
Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies
Founded:2017
Firm Location:San Francisco, California • Cambridge, Massachusetts • China • Stanford, California • San Francisco Bay Area
Investor Firms That Co-Invest with Pivotal bioVenture Partners
Domain AssociatesRiverVest
Pivotal bioVenture Partners Team
Photo of Glenn Batchelder, Venture Partner at Pivotal bioVenture Partners
Glenn Batchelder
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed)
to see your intro paths to Glenn
Photo of Peter Bisgaard, Managing Director at Pivotal bioVenture Partners
Peter Bisgaard
Pivotal bioVenture Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
to see your intro paths to Peter
Photo of Joseph Charalel, Senior Associate at Pivotal bioVenture Partners
Joseph Charalel
Pivotal bioVenture Partners·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Stanford (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed)
to see your intro paths to Joseph
Photo of Vincent Cheung, Managing Director at Pivotal bioVenture Partners
Vincent Cheung
Pivotal bioVenture Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in China
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Real Estate/PropTech (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Vincent
Photo of Rob Hopfner, Managing Partner at Pivotal bioVenture Partners
Rob Hopfner
Pivotal bioVenture Partners·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B)
to see your intro paths to Rob
Photo of Ash Khanna, Partner at Pivotal bioVenture Partners
Ash Khanna
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
to see your intro paths to Ash
Photo of Jennifer Lee, Partner at Pivotal bioVenture Partners
Jennifer Lee
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Jennifer
Photo of Benjamin Li, Senior Associate at Pivotal bioVenture Partners
Benjamin Li
Pivotal bioVenture Partners·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
to see your intro paths to Benjamin
Photo of Lisa Marrone, Investor at Pivotal bioVenture Partners
Lisa Marrone
Sweet spot: $5.0M
Range: $1M - $30.0M
Investors in San Francisco (CA), Investors in SF Bay Area (CA), Investors in Palo Alto (CA), Investors in Menlo Park (CA), Investors in San Jose (CA)
Investors in TransportationTech (Series B), Investors in AI (Series B), Investors in TransportationTech (Series A), Investors in E-commerce (Series B), Investors in E-commerce (Series A), Investors in Consumer Internet (Series B), Investors in Insurance (Series B), Investors in Marketplaces (Series B), Investors in Real Estate/PropTech (Series B), Investors in Real Estate/PropTech (Series A), Investors in Insurance (Series A), Investors in FinTech (Series B), Investors in Marketplaces (Series A), Investors in AI (Series A), Investors in Health IT (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in TransportationTech (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in E-commerce (Series A), Investors in Insurance (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in Consumer Internet (Series B), Investors in Real Estate/PropTech (Series A), Investors in FinTech (Series B), Investors in AI (Series B), Investors in TransportationTech (Series B), Investors in E-commerce (Series B), Investors in Health IT (Series B), Investors in Insurance (Series B), Investors in Marketplaces (Series B), Investors in Real Estate/PropTech (Series B), Investors in Future of Work (Series A), Investors in Future of Work (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Health IT (Series B)
to see your intro paths to Lisa
Photo of Brian Mills, Senior Associate at Pivotal bioVenture Partners
Brian Mills
Pivotal bioVenture Partners·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A)
to see your intro paths to Brian
Photo of Qian Wang, Principal at Pivotal bioVenture Partners
Qian Wang
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
to see your intro paths to Qian